Stay updated on MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial

Sign up to get notified when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a Locations section with Pennsylvania as a listed site. The HHS Vulnerability Disclosure link and the Pennsylvania Locations entry were removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T14:52:26.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Publications section wording updated to clarify that publications are provided by the person entering information about the study, and the revision number is changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:45:12.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Notice about government funding and operating status has been removed from the page. All substantive study details (title, eligibility criteria, endpoints, and participation information) remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:26:01.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The screenshots show only minor formatting and layout adjustments; there are no changes to core study details like eligibility criteria, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:29:37.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and updated version to v3.2.0; - Removed the resource on Mature T-cell and NK-cell non-Hodgkin lymphoma (GRDIC).
    Difference
    3%
    Check dated 2025-10-06T06:59:29.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:42:48.000Z thumbnail image

Stay in the know with updates to MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.